| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 8 | US FAERS | |
| 2 | Paroxetine | FAERS: 7 | US FAERS | |
| 3 | Ceftriaxone | FAERS: 2 | US FAERS | |
| 4 | Fluoxetine | FAERS: 1 | US FAERS | |
| 5 | Pivampicillin | FAERS: 1 | US FAERS | |
| 6 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 7 | Sorafenib | FAERS: 1 | US FAERS | |
| 8 | Valproic Acid | FAERS: 1 | US FAERS | |
| 9 | Cytarabine | OFFSIDES | ||
| 10 | Mitoxantrone | OFFSIDES | ||
| 11 | Sumatriptan | OFFSIDES | ||
| 12 | Sunitinib | OFFSIDES | ||
| 13 | Tretinoin | OFFSIDES | ||
| 14 | fludarabine phosphate | OFFSIDES | ||
| 15 | fludarabine | OFFSIDES | ||
| 16 | tegaserod | OFFSIDES | ||
| 17 | tegaserod | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.